Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Emergent Biosolutions gains on earnings report
Marketwatch
Friday, March 9, 2012 - 4:22pm
tags:
earnings, Emergent BioSolutions
Peregrine's cancer drug data disappoints; shares plunge
Reuters
Friday, March 9, 2012 - 4:21pm
tags:
Peregrine Pharmaceuticals, bavituximab, non-small cell lung cancer
GlaxoSmithKline: This 5% Yielder Is Looking Resurgent
Seeking Alpha
Friday, March 9, 2012 - 4:20pm
tags:
GSK
Merck: Strong Pipeline For Dividend Growth
Seeking Alpha
Friday, March 9, 2012 - 4:20pm
tags:
Merck, dividends, GSK, Bristol-Myers Squibb, Pfizer, Sanofi
Novartis' Pipeline Spells Out Strong Growth Potential
Seeking Alpha
Friday, March 9, 2012 - 4:19pm
tags:
Novartis
Big trouble seen for targeted cancer drugs
Fierce Biotech
Friday, March 9, 2012 - 11:27am
tags:
targeted therapeutics, cancer, UK
Speculative Biotech For The Iron-Stomached
Seeking Alpha
Friday, March 9, 2012 - 10:53am
tags:
Geron, Keryx, Dendreon, Advanced Cell Technology, Aeterna Zentaris
A Picture is Worth a Thousand Words: The Difference Between "Yes" and "No" During an FDA Advisory Committee
Elsevier Business
Friday, March 9, 2012 - 10:49am
tags:
FDA, advisory panels, Xgeva, Amgen, Vivus, Qnexa
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up
Xconomy
Friday, March 9, 2012 - 10:47am
tags:
prostate cancer, OncoGenex, custirsen
Anaysis - AstraZeneca gets serious on deals as drugs run out
Reuters
Friday, March 9, 2012 - 10:45am
tags:
M&A, AstraZeneca
Boehringer Ingelheim unit Bedford Labs recalling cancer drug cytarabine
Yahoo/AP
Friday, March 9, 2012 - 10:44am
tags:
Bedford Labs, Boehringer Ingelheim, recalls, cancer, cytarabine
DepoMed Beats on Both Top and Bottom Lines
Motley Fool
Friday, March 9, 2012 - 10:40am
tags:
Depomed, earnings
Weight loss drug developer Orexigen posts smaller 4th-quarter loss as costs decrease
Yahoo/AP
Friday, March 9, 2012 - 10:39am
tags:
earnings, Orexigen
Checking an Important Metric at Allergan
Motley Fool
Friday, March 9, 2012 - 10:39am
tags:
Allergan
AstraZeneca citizen petitions on Quetiapine labeling receives FDA response
Yahoo/Fly on the Wall
Friday, March 9, 2012 - 10:31am
tags:
AstraZeneca, FDA, Quetiapine, generics, Seroquel
Merck's hepatitis C drug wins UK cost endorsement
Reuters
Friday, March 9, 2012 - 10:29am
tags:
Merck, UK, hepatitis C, Victrelis
Bellicum snags $20M for mid-stage cancer vaccine program
Fierce Biotech
Thursday, March 8, 2012 - 3:33pm
tags:
BPX-101, prostate cancer, Bellicum
U.S. could bring more common drugs over the counter
Reuters
Thursday, March 8, 2012 - 3:26pm
tags:
OTC, FDA
AIDS Cure Quest Advances as Merck Cancer Drug Attacks Hidden HIV
Bloomberg
Thursday, March 8, 2012 - 3:23pm
tags:
AIDS, Merck, HIV, Zolinza
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thursday, March 8, 2012 - 10:15am
tags:
JNJ, prostate cancer, Dendreon, Provenge, Medivation, Zytiga, MDV3100

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.